Enfusion Inc.

NYSE: ENFN · Real-Time Price · USD
10.76
-0.04 (-0.37%)
At close: Apr 17, 2025, 3:59 PM

Enfusion Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
3.92M 9.25M -13.26M -282.24M
Depreciation & Amortization
11.75M 9.99M 6.34M 3.98M
Stock-Based Compensation
19.03M 7.46M 24.99M 289.8M
Other Working Capital
n/a -6.12M 4.27M -1.9M
Other Non-Cash Items
-20K 8.37M 1.68M 222K
Deferred Income Tax
n/a n/a n/a 2.67M
Change in Working Capital
n/a -9.44M -5.6M -14.74M
Operating Cash Flow
34.68M 25.63M 14.16M -318K
Capital Expenditures
-3.63M -9.67M -7.93M -8.01M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-10.26M -5.22M -3.95M -1.92M
Investing Cash Flow
-13.89M -9.67M -7.93M -8.01M
Debt Repayment
n/a n/a n/a -100M
Common Stock Repurchased
n/a n/a -7.96M -87.85M
Dividend Paid
n/a n/a n/a -3.28M
Other Financial Acitivies
-1.4M -60.41M -7.96M -10.57M
Financial Cash Flow
-1.4M -43.08M -7.96M 58.85M
Net Cash Flow
18.88M -26.94M -1.82M 50.43M
Free Cash Flow
31.05M 15.96M 6.22M -8.33M